Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG CLASS:
SSTR agonist
DRUG CLASS:
SSTR agonist
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Related drugs:
‹
lanreotide prolonged-release subcutaneous (2)
DG3173 (1)
octreotide extended release (0)
octreotide acetate (0)
vapreotide (0)
pasireotide long acting release (0)
Debio 4126 (0)
octreotide acetate solution for injection (0)
CAM2029 (0)
MTD201 (0)
lanreotide prolonged-release subcutaneous (2)
DG3173 (1)
octreotide extended release (0)
octreotide acetate (0)
vapreotide (0)
pasireotide long acting release (0)
Debio 4126 (0)
octreotide acetate solution for injection (0)
CAM2029 (0)
MTD201 (0)
›
Associations
(3)
News
Trials
VERI cancer hierarchy
Reset Filters
No biomarker
Neuroendocrine Tumor
No biomarker
Neuroendocrine Tumor
lanreotide prolonged-release subcutaneous
Sensitive: A1 - Approval
lanreotide prolonged-release subcutaneous
Sensitive
:
A1
lanreotide prolonged-release subcutaneous
Sensitive: A1 - Approval
lanreotide prolonged-release subcutaneous
Sensitive
:
A1
SSTR positive
Neuroendocrine Tumor
SSTR positive
Neuroendocrine Tumor
lanreotide prolonged-release subcutaneous
Sensitive: A2 - Guideline
lanreotide prolonged-release subcutaneous
Sensitive
:
A2
lanreotide prolonged-release subcutaneous
Sensitive: A2 - Guideline
lanreotide prolonged-release subcutaneous
Sensitive
:
A2
No biomarker
Meningioma
No biomarker
Meningioma
DG3173
Sensitive: A2 - Guideline
DG3173
Sensitive
:
A2
DG3173
Sensitive: A2 - Guideline
DG3173
Sensitive
:
A2
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login